CELG
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F2564522&ei=oIaaUpjiMKTisQeQfQ&usg=AFQjCNGsHzMDWpSX3a1GSeBD63cQ2kZBqA
Celgene Corporation Reaffirms FY 2012 And FY 2015 Guidance; Comments On FY 2013 EPS Guidance-Conference Call
Thursday, 21 Jun 2012 08:30am EDT
Celgene Corporation announced that for fiscal 2012, the Company reaffirmed its guidance with total global revenues in the range of $5.4 billion to $5.6 billion. The Company also reaffirmed its fiscal 2012 earnings per share (EPS) guidance of $4.70 to $4.80. For fiscal 2013, the Company expects to produce EPS growth in the mid to high teams over fiscal 2012 EPS midpoint. For fiscal 2015, the Company also maintains its high-level financial targets of $8 billion to $9 billion of total revenues and $8 to $9 of earnings per share. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $5.5 billion and EPS of $4.79 for fiscal 2012; EPS of $5.59 for fiscal 2013; and revenue of $8 billion and EPS of $8 for fiscal 2015.Â 
